Glen Forneris, | |
1021 N Mulford Rd, Rockford, IL 61107-3877 | |
(815) 387-5600 | |
(815) 316-4726 |
Full Name | Glen Forneris |
---|---|
Gender | Male |
Speciality | Social Worker - Clinical |
Location | 1021 N Mulford Rd, Rockford, Illinois |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1073021192 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1041C0700X | Social Worker - Clinical | 149017684 (Illinois) | Primary |
Mailing Address | Practice Location Address |
---|---|
Glen Forneris, 1021 N Mulford Rd, Rockford, IL 61107-3877 Ph: (815) 387-5600 | Glen Forneris, 1021 N Mulford Rd, Rockford, IL 61107-3877 Ph: (815) 387-5600 |
News Archive
Keryx Biopharmaceuticals, Inc. today announced positive top-line results from the Phase 3 short-term efficacy study component of its Phase 3 registration program of Zerenex (ferric citrate), the Company's ferric iron-based phosphate binder for the treatment of elevated serum phosphorus levels, or hyperphosphatemia, in patients with end-stage renal disease on dialysis.
Men with Stage IV breast cancer and known estrogen (ER) and progesterone receptor (PR) status benefit from surgical intervention and from trimodal therapy (systemic therapy, surgery, and radiation), according to a study presented at the virtual American College of Surgeons (ACS) Clinical Congress 2021.
Scientists in the Department of Biomedical Engineering at Texas A&M University are developing new ways to advance the field of regenerative medicine and cancer treatment. They are developing a 2D nanosheet that is 1,000 times smaller than a strand of hair.
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that its subsidiary OphthaliX Inc. released results from a 24 week, placebo-controlled phase III study involving 237 patients with moderate-to-severe Dry Eye Syndrome who were treated with its licensed drug CF101, an A3 adenosine receptor agonist.
› Verified 7 days ago
Kelly Finch, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 4320 Spring Creek Rd, Ste 19, Rockford, IL 61107 Phone: 815-222-9485 | |
Mrs. Jessica M Gregg, MSW LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 5758 Elaine Dr Ste 101c, Rockford, IL 61108 Phone: 815-975-1177 | |
Miss Marcy L Turek, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 1601 Parkview Ave, University Psychiatric Services, Rockford, IL 61107 Phone: 815-395-5874 Fax: 815-395-5644 | |
Stephanie A Johnson, LCSW Clinical Social Worker Medicare: May Accept Medicare Assignments Practice Location: 4835 Manhattan Dr Ste 4, Rockford, IL 61108 Phone: 815-520-2303 | |
Mrs. Kelley Nicole Larson, LSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 301 E State St, Rockford, IL 61104 Phone: 815-668-7810 | |
Dana Stephen Kiley, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 2823 Glenwood Ave, Rockford, IL 61101 Phone: 815-968-5342 Fax: 815-968-4656 | |
Paula Tripodi, L.C.S.W. Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 6735 Vistagreen Way Ste 210, Rockford, IL 61107 Phone: 815-742-7489 Fax: 815-904-6419 |